Category Archives: Business and Investments

Latest From Business and Investments

Don’t Go At It Alone- BIO BizLink and the Evolving R&D Marketplace

b9e35848296c8b6718258607ece28d99

With companies in the biotechnology industry more frequently outsourcing R&D pipelines, selecting the right contract organization becomes more important. BIO, along with OnDeckBiotech, has recently launched a new online platform, BIO BizLink, that facilitates these relationships between biopharma companies and contract service providers. BIO BizLink serves as a peer-rated database for contract manufacturing organizations (CMOs) and contract research organizations (CROs) and their specific capabilities, while additionally providing secure project management tools to help companies work Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Boston Globe: Helping veterans find a career path in life sciences

Veterans_day

Mike Minogue, chairman and chief executive of Abiomed, a medical device company in Boston that makes tiny heart pumps, leads a program to help veterans transition to the civilian workforce into life sciences careers. Today, Shirley Leung of the Boston Globe profiles Minogue and a program that he launched, MedTech & BioTech Veterans Program, which has organized close to a dozen boot camps for more than 500 veterans across the country and recruited more than 30 life-sciences companies to serve Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

SPARKs Fly When Stanford Profs Talk BD with Industry Leads

TheHill

5:30 PM, October 8th, 2014. Li Ka Shing Learning & Knowledge Center, Stanford University. Stanford’s SPARK Seminar Series provides a forum where BD leads can meet with aspiring academics to foster better collaboration and tech transfer. That said, much of the forum’s discussion has applicability outside of academia as well. Today Kanad Das (no relation), Associate Director of Partnering and Alliance Management at SPARK, has assembled a dream team of industry business development frontrunners to Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Investor Forum Closing Plenary: How Fragile is the Biotech Rally After Five Positive Years?

2

Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, “How fragile is the biotech rally after five positive years?” Moderated by Todd Foley, Managing Director, MPM Capital, the panel included: Rachel King, CEO, GlycoMimetics and Chair, BIO Ellen Lubman, VP Strategy and Innovation, Forest Laboratories Vijay Murthy, Director, Ventures and Early Stage Collaborations, AbbVie Michael A. Margolis, RPh, Managing Director, ROTH Capital Partners Doug Fambrough, PhD, CEO, Dicerna Pharmaceuticals Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

Answering the Call for Cures in Michigan

21st-Century-Cures--Free

This week, the Kalamazoo Gazette published an op-ed on how we can accelerate the discovery, development and delivery of treatments and cures for patients written by Stephen Rapundalo, President and CEO of MichBio, and BIO’s Jim Greenwood. The op-ed highlights the focus of roundtable discussions being held across the country as part of the 21st Century Cures Initiative. The U.S. House of Representatives’ Energy and Commerce Committee launched the initiative – led by Chairman Fred Read More >

Business and Investments, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,